Gregory T Carter

Summary

Publications

  1. doi request reprint Using palliative care in progressive neuromuscular disease to maximize quality of life
    Gregory T Carter
    Department of Physical Medicine and Rehabilitation, University of California at Davis, Sacramento, CA 95817, USA
    Phys Med Rehabil Clin N Am 23:903-9. 2012
  2. doi request reprint Disease burden in neuromuscular disease: the role of chronic pain
    Gregory T Carter
    Olympia Physical Medicine, 410 Providence Lane, Building 2, Olympia, WA 98506, USA
    Phys Med Rehabil Clin N Am 23:719-29. 2012
  3. pmc Psychoactive substances and the political ecology of mental distress
    Sunil K Aggarwal
    Department of Physical Medicine and Rehabilitation, New York University, Rusk Institute of Rehabilitation Medicine, 400 E 34th St, New York, NY 10016 USA
    Harm Reduct J 9:4. 2012
  4. doi request reprint Cannabis in palliative medicine: improving care and reducing opioid-related morbidity
    Gregory T Carter
    Hospice Services, Providence Medical Group, Olympia, WA 98531, USA
    Am J Hosp Palliat Care 28:297-303. 2011
  5. doi request reprint Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials
    Gregory T Carter
    Muscular Dystrophy Association Amyotrophic Lateral Sclerosis Center, University of Washington Medical Center, Seattle, WA, USA
    Am J Hosp Palliat Care 27:347-56. 2010
  6. doi request reprint Aging with muscular dystrophy: pathophysiology and clinical management
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 21:429-50. 2010
  7. pmc Pain in persons with postpolio syndrome: frequency, intensity, and impact
    Brenda L Stoelb
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195 6490, USA
    Arch Phys Med Rehabil 89:1933-40. 2008
  8. ncbi request reprint Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
    Sunil K Aggarwal
    University of Washington, Seattle, Washington, USA
    J Opioid Manag 5:257-86. 2009
  9. ncbi request reprint From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of "plum" cannabis flowers to medical marijuana patients in Washington State
    Sunil K Aggarwal
    Department of Physical Medicine and Rehabilitation, New York University, Rusk Institute of Rehabilitation Medicine, New York, NY 10016, USA
    J Psychoactive Drugs 45:141-55. 2013
  10. ncbi request reprint Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy
    Michael D Weiss
    University of Washington Medical Center, Seattle, WA 98195, USA
    Expert Opin Pharmacother 5:735-46. 2004

Detail Information

Publications49

  1. doi request reprint Using palliative care in progressive neuromuscular disease to maximize quality of life
    Gregory T Carter
    Department of Physical Medicine and Rehabilitation, University of California at Davis, Sacramento, CA 95817, USA
    Phys Med Rehabil Clin N Am 23:903-9. 2012
    ....
  2. doi request reprint Disease burden in neuromuscular disease: the role of chronic pain
    Gregory T Carter
    Olympia Physical Medicine, 410 Providence Lane, Building 2, Olympia, WA 98506, USA
    Phys Med Rehabil Clin N Am 23:719-29. 2012
    ..Better measurement tools for chronic pain, quality of life, and burden of disease are needed and could be used via NMD registries to address the knowledge gap in this area...
  3. pmc Psychoactive substances and the political ecology of mental distress
    Sunil K Aggarwal
    Department of Physical Medicine and Rehabilitation, New York University, Rusk Institute of Rehabilitation Medicine, 400 E 34th St, New York, NY 10016 USA
    Harm Reduct J 9:4. 2012
    ..It closes with proposing a non-criminalizing public health approach for regulating human close contact with psychoactive substances using the example of cannabis use...
  4. doi request reprint Cannabis in palliative medicine: improving care and reducing opioid-related morbidity
    Gregory T Carter
    Hospice Services, Providence Medical Group, Olympia, WA 98531, USA
    Am J Hosp Palliat Care 28:297-303. 2011
    ..Using this foundation, an argument is made for reclassifying cannabis in the context of improving palliative care and reducing opioid-related morbidity...
  5. doi request reprint Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials
    Gregory T Carter
    Muscular Dystrophy Association Amyotrophic Lateral Sclerosis Center, University of Washington Medical Center, Seattle, WA, USA
    Am J Hosp Palliat Care 27:347-56. 2010
    ....
  6. doi request reprint Aging with muscular dystrophy: pathophysiology and clinical management
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 21:429-50. 2010
    ..A comprehensive medical and rehabilitative approach to management of aging MD patients can often fulfill expectations and help them enjoy an enhanced quality of life...
  7. pmc Pain in persons with postpolio syndrome: frequency, intensity, and impact
    Brenda L Stoelb
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98195 6490, USA
    Arch Phys Med Rehabil 89:1933-40. 2008
    ..To describe the frequency, intensity, and impact of pain in persons with postpoliomyelitis syndrome (PPS)...
  8. ncbi request reprint Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
    Sunil K Aggarwal
    University of Washington, Seattle, Washington, USA
    J Opioid Manag 5:257-86. 2009
    ..This study was conducted to better understand the characteristics of chronic pain patients seeking treatment with medicinal cannabis (MC)...
  9. ncbi request reprint From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of "plum" cannabis flowers to medical marijuana patients in Washington State
    Sunil K Aggarwal
    Department of Physical Medicine and Rehabilitation, New York University, Rusk Institute of Rehabilitation Medicine, New York, NY 10016, USA
    J Psychoactive Drugs 45:141-55. 2013
    ....
  10. ncbi request reprint Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy
    Michael D Weiss
    University of Washington Medical Center, Seattle, WA 98195, USA
    Expert Opin Pharmacother 5:735-46. 2004
    ..Based on the available data, it is our opinion that combination drug therapies should be considered for future clinical trials...
  11. pmc Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy
    Mark P Jensen
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle 98195 6490, USA
    Arch Phys Med Rehabil 89:320-8. 2008
    ..To determine the nature and scope of pain in working-aged adults with myotonic muscular dystrophy (MMD) and facioscapulohumeral muscular dystrophy (FSHD)...
  12. doi request reprint Exercise in neuromuscular diseases
    R Ted Abresch
    Department of Rehabilitation Medicine, University of California, Davis, 4860 Y Street Suite, 3850, Sacramento, CA 95817, USA
    Phys Med Rehabil Clin N Am 23:653-73. 2012
    ..In addition to traditional measures of exercise efficacy, outcome variables should include measures of functional status and health-related quality of life...
  13. ncbi request reprint Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Gregory T Carter
    Muscular Dystrophy Association Amyotrophic Lateral Sclerosis Center, University of Washington School of Medicine, Seattle, WA 98195, USA
    IDrugs 6:147-53. 2003
    ..We indicate current and future directions in research and clinical trials, and also argue that a logical next step for clinical trials in ALS should be combination drug treatment...
  14. ncbi request reprint Chronic pain in persons with neuromuscular disease
    Mark P Jensen
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA 98195 6490, USA
    Arch Phys Med Rehabil 86:1155-63. 2005
    ..To examine the nature and scope of pain in persons with neuromuscular disorder (NMD)...
  15. ncbi request reprint Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington, USA
    Am J Hosp Palliat Care 22:55-9. 2005
    ..1 (SD 5.4), with p < 0.01. This pilot study suggests that modafinil is well-tolerated and may reduce symptoms of fatigue in ALS. Further blinded, controlled studies of modafinil in larger numbers of ALS patients are warranted...
  16. ncbi request reprint Axonal degeneration in the Trembler-j mouse demonstrated by stimulated single-fiber electromyography
    Gregg D Meekins
    Department of Neurology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Muscle Nerve 36:81-6. 2007
    ..This technique may be a valuable tool to study the affects of genetic or pharmaceutical interventions in murine models of peripheral neuropathy. Muscle Nerve, 2007...
  17. ncbi request reprint Electromyographic studies in mdx and wild-type C57 mice
    Jay J Han
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, USA
    Muscle Nerve 33:208-14. 2006
    ..This is important as there are few objective measures of muscle function in murine models that do not require killing the animal...
  18. ncbi request reprint Medical marijuana: emerging applications for the management of neurologic disorders
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, 1959 NE Pacific Avenue, Box 356490, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 15:943-54, ix. 2004
    ..This article reviews the current and emerging research on the physiologic mechanisms of endogenous and exogenous cannabinoids and their applications in the management of neurologic disease...
  19. pmc Psychosocial factors and adjustment to pain in individuals with postpolio syndrome
    Adam T Hirsh
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington 98104, USA
    Am J Phys Med Rehabil 89:213-24. 2010
    ..The purpose of the current study was to examine the associations among measures of psychosocial factors, pain, and adjustment in persons with postpoliomyelitis syndrome...
  20. pmc Pain in youths with neuromuscular disease
    Joyce M Engel
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington 98195, USA
    Am J Hosp Palliat Care 26:405-12. 2009
    ..This study indicates that chronic pain is a significant problem in youths with NMD. These data strongly support making comprehensive pain assessment and management an integral part of the standard of care for youths with NMD...
  21. doi request reprint Drug therapy in amyotrophic lateral sclerosis
    B Jane Distad
    Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 19:633-51, xi-xii. 2008
    ..The authors review the current understanding of the pathogenic mechanisms of ALS and approaches to treating the disease...
  22. pmc Coping with chronic pain among younger, middle-aged, and older adults living with neurological injury and disease
    Ivan Molton
    University of Washington School of Medicine, USA
    J Aging Health 20:972-96. 2008
    ..Discussion. These data suggest differences in the quantity and quality of pain coping among age groups...
  23. ncbi request reprint Chronic pain in persons with neuromuscular disease
    Amy J Hoffman
    Department of Rehabilitation Medicine, Box 356490, University of Washington School of Medicine, Seattle, WA 98195 6490, USA
    Phys Med Rehabil Clin N Am 16:1099-112, xii. 2005
  24. ncbi request reprint Medicinal cannabis: rational guidelines for dosing
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA 98531, USA
    IDrugs 7:464-70. 2004
    ..This paper will review the known chemistry and pharmacology of cannabis and, on that basis, discuss rational guidelines for dosing...
  25. ncbi request reprint The reliability and validity of a self-report version of the FIM instrument in persons with neuromuscular disease and chronic pain
    Mark P Jensen
    Department of Rehabilitation Medicine, University of Washington, Seattle, WA 98195, USA
    Arch Phys Med Rehabil 86:116-22. 2005
    ..To evaluate the reliability and validity of a self-report version of the FIM instrument (FIM-SR)...
  26. doi request reprint The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy
    Seth D Friedman
    Department of Radiology, Seattle Children s Hospital, 4800 Sandpoint Way, Room R4488, Seattle, Washington 98105, USA
    Muscle Nerve 45:500-6. 2012
    ..We used a one-step quantitative magnetic resonance imaging (MRI) method to evaluate muscle, edema, and fat in patients spanning the range of severity...
  27. ncbi request reprint Survey of cannabis use in patients with amyotrophic lateral sclerosis
    Dagmar Amtmann
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington, USA
    Am J Hosp Palliat Care 21:95-104. 2004
    ..Cannabis was reported ineffective in reducing difficulties with speech and swallowing, and sexual dysfunction. The longest relief was reported for depression (approximately two to three hours)...
  28. ncbi request reprint The importance of assessing quality of life in patients with neuromuscular disorders
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Centralia, WA 98531, USA
    Am J Hosp Palliat Care 23:493-7. 2006
  29. ncbi request reprint Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington, USA
    Am J Hosp Palliat Care 23:412-6. 2006
    ..We report 4 patients with genetically confirmed Charcot-Marie-Tooth disease who had significant fatigue that was almost completely relieved by modafinil...
  30. ncbi request reprint Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions
    Sunil K Aggarwal
    Medical Scientist Training Program, University of Washington, Seattle, WA, USA
    J Opioid Manag 5:153-68. 2009
    ..This article reviews the current and emerging research on the physiological mechanisms of cannabinoids and their applications in managing chronic pain, muscle spasticity, cachexia, and other debilitating problems...
  31. ncbi request reprint Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease
    Richard T Abresch
    University of California, Davis, Department of Physical Medicine and Rehabilitation, USA
    Am J Hosp Palliat Care 19:39-48. 2002
    ..In conclusion, with the exception of adult SMA, the frequency and severity of pain reported in slowly progressive NMDs was significant...
  32. ncbi request reprint Using electromyography to assess function in humans and animal models of muscular dystrophy
    Jay J Han
    Department of Physical Medicine and Rehabilitation, University of California Davis, 4860 Y Street, Suite 3850, Sacramento, CA 95817, USA
    Phys Med Rehabil Clin N Am 16:981-97, x. 2005
  33. doi request reprint Rehabilitation management of neuromuscular disease: the role of exercise training
    R Ted Abresch
    Department of Physical Medicine and Rehabilitation, University of California, Davis, Davis, CA, USA
    J Clin Neuromuscul Dis 11:7-21. 2009
    ..This review focuses on the role of exercise in a few of the specific NMDs where most research has taken place and recommends future research directions...
  34. pmc Dosing medical marijuana: rational guidelines on trial in Washington State
    Sunil K Aggarwal
    University of Washington School of Medicine, Seattle, USA
    MedGenMed 9:52. 2007
  35. doi request reprint Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma
    Timothy Feyma
    Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195, USA
    Muscle Nerve 38:916-20. 2008
    ..Therefore, abnormal CTG repeat expansions in the gene could lead to the development of thymoma and myasthenia gravis...
  36. doi request reprint New clinical end points in rehabilitation medicine: tools for measuring quality of life
    Richard T Abresch
    Department of Physical Medicine and Rehabilitation, University of California at Davis, Sacramento, CA 95616, USA
    Am J Hosp Palliat Care 26:483-92. 2009
    ..The goals for this article are to show the value of performing HRQoL measurements and briefly describe methods used to assess quality of life (QoL)...
  37. doi request reprint Preface: the state of the science of all motor neuron diseases
    Michael D Weiss
    Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Room NN282A, Box 356115, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 19:xix-xx. 2008
  38. ncbi request reprint Electrodiagnostic evaluation of hereditary motor and sensory neuropathies
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, 1959 Northeast Pacific Avenue, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 14:347-63, ix-x. 2003
    ..Nevertheless, there are exceptions. This article reviews the available literature and describes the electrodiagnostic approach to HMSN, detailing potential sources of error that can lead to misinterpretation of data...
  39. ncbi request reprint Iatrogenic axillary neuropathy after intramuscular injection of the deltoid muscle
    Loren T Davidson
    Department of Physical Medicine and Rehabilitation, University of California Davis Medical Center, 4860 Y Street, Sacramento, CA 95817, USA
    Am J Phys Med Rehabil 86:507-11. 2007
    ....
  40. ncbi request reprint Body composition and water compartment measurements in boys with Duchenne muscular dystrophy
    Craig M McDonald
    Department of Physical Medicine and Rehabilitation, University of California Davis School of Medicine, Davis, California, USA
    Am J Phys Med Rehabil 84:483-91. 2005
    ....
  41. ncbi request reprint Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis
    Patrick Weydt
    Department of Neurology, University of Washington School of Medicine, 1959 Northeast Pacific Avenue, Seattle, WA 98195, USA
    Curr Opin Investig Drugs 3:1720-4. 2002
    ..This article reviews the current research in this area and discusses theoretical and clinical ramifications of these recent findings...
  42. doi request reprint The amyotrophic lateral sclerosis center: a model of multidisciplinary management
    Angeli S Mayadev
    Department of Physical Medicine and Rehabilitation, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195, USA
    Phys Med Rehabil Clin N Am 19:619-31, xi. 2008
    ..This article provides a summary of the current research into the rehabilitation of ALS, including the role of exercise, spasticity management, mood disorders, pain, and palliative care...
  43. ncbi request reprint Amyotrophic lateral sclerosis: practical aspects of care
    Lisa S Krivickas
    Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA
    J Spinal Cord Med 25:274-6. 2002
  44. doi request reprint Skeletal muscle edema in muscular dystrophy: clinical and diagnostic implications
    Sandra L Poliachik
    Department of Radiology, Seattle Children s Hospital, Seattle, WA 98105, USA
    Phys Med Rehabil Clin N Am 23:107-22, xi. 2012
    ..Lastly, refining current techniques and adapting other MRI capabilities may enhance detection and assessment of edema for better evaluation of disease progression and treatment outcomes...
  45. ncbi request reprint Cannabis: old medicine with new promise for neurological disorders
    Gregory T Carter
    Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle 98531, USA
    Curr Opin Investig Drugs 3:437-40. 2002
    ..This article reviews the emerging research on the physiological mechanisms of endogenous and exogenous cannabinoids in the context of neurological disease...
  46. ncbi request reprint Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes
    Julie A Hodapp
    Department of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle, USA
    Arch Neurol 63:112-7. 2006
    ..Mutations in the peripheral myelin protein 22 (PMP-22) gene are the most common cause of Charcot-Marie-Tooth neuropathy and may rarely occur in combination with other neurogenetic diseases...
  47. ncbi request reprint Medical marijuana: politics trumps science at the FDA
    Gregory T Carter
    University of Washington School of Medicine, Seattle, Washington, USA
    MedGenMed 8:46. 2006
  48. ncbi request reprint Adaptations to exercise training and contraction-induced muscle injury in animal models of muscular dystrophy
    Gregory T Carter
    Department of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle, Washington, USA
    Am J Phys Med Rehabil 81:S151-61. 2002
    ....
  49. doi request reprint Electrodiagnosis in persons with amyotrophic lateral sclerosis
    Nanette C Joyce
    Department of Physical Medicine and Rehabilitation, University of California, Davis School of Medicine, 4860 Y St, Suite 3850, Sacramento, CA 95817, USA
    PM R 5:S89-95. 2013
    ....